TruScreen Group (TRU) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
31 Jul, 2026Opening remarks and agenda
Meeting opened virtually, confirming quorum and proper notice to shareholders.
Agenda included introduction, general discussion, and eight formal resolutions.
Voting conducted by poll, with electronic voting cards and proxies representing about 29% of issued capital.
Board and executive committee updates
Introduction of directors: Christine Pears (Audit Committee Chair), Dexter Cheung (Technology Committee Chair), and new director Reece O'Connell.
CFO and Company Secretary Guy Robertson and CEO Marty Dillon also in attendance.
Specific resolutions to be voted on
Approval and rectification of 109,999,995 shares issued under NZX Listing Rule 4.5.1.
Approval of 17,690,476 oversubscribed placement shares at NZD 0.014 per share.
Issue of attaching options (one for two) to placement shares and oversubscribed shares.
Approval of 25,200,000 broker options to joint lead managers.
Approval of 1 million shares to CFO for services rendered.
Approval of 22.5 million options to directors, with directors excluded from voting.
Approval of 22,188,094 oversubscribed rights shares at NZD 0.013 per share.
Latest events from TruScreen Group
- FY2025 sales fell on rollout delays, but FY2026 is set for strong growth with new markets and alliances.TRU
H2 2025 - Revenue down 17% to NZ$860k; capital raised and public programs set to drive 2H growth.TRU
H1 2026 - Sales up 42% YOY, gross margin 31.5%, and $4m raised to fund global expansion.TRU
H2 2026 - AI-driven cervical cancer screening device posts rapid sales growth and global expansion.TRU
Investor presentation - AI-driven cervical cancer screening sales up 27% YOY, led by China and LMIC expansion.TRU
Investor presentation - FY26 sales projected to surpass NZ$2.8m as public programs and new markets accelerate growth.TRU
Investor presentation - FY26 growth is driven by public program expansion, new markets, and product diversification.TRU
AGM 2025 - Sales up 5% year-over-year, with narrowed operating loss and expanding global adoption.TRU
H1 2025 - Strong sales growth, global expansion, and cost control drive TruScreen toward cash flow positivity.TRU
AGM 2024 Presentation